Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GLGC Gene Logic -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (239)	12/16/2006 1:48:58 PM
From: Mike McFarland	Respond to of 360

Lately, news releases late in the week I think generate a opening pop, and then a drift down in the following week--not much of a play there for any but the trickiest traders. Still, $15M is a nice chunk of change-- and much needed for a company that seems willing to blow through that kind of money pretty quick (isn't that the sort of money they burned through in single quarters this past year?!) I put together a position over the past few weeks, but probably wont try and get anything out of the Monday pop--not enough of a pay off. You only take a risk on a company like this for the greater payoff--if they manage to do exactly what they are trying to do: Rescue something out of these old chemical libraries. That's how I see it. Of course, I can imagine any number of alternatives for GLGC. An outright buyout, lowball offer--it is entirely possible that MLNM's Horizon techology has been developed (at glgc's expense) and now can be bought back pretty cheaply. I don't think it would take much of an offer to round up a lot of shares. What do you think of that 10% plus position. Some late industrialist's trust fund or something. Google gene logic 10% owner naples florida miller lloyd and that will come up. They bought the latest batch at $1.40, I was putting in market orders around that time and I sure as hell didn't get any prices near that good. I'm in a dime higher (of course, that is my cost--Milfam's trust average price is probably a lot higher). I also wonder about even something like Kalypsys, they just raised $100M--probably looking for a ticker. But I've no idea if the robotic screening and glgc's genomic tech is a good fit or not. And the locations are all wrong, San Deigo and Maryland. ~$50M cash hardly seems worth the effort if you can get that sort of money from the VC's.) I think we are in the age of hedge funds and VC's. In the end...we will probably take it in the end, ha. Down 99% from the all time high, and it may end up that way. I'm cynical. Shareholders new and old alike could still end up getting the big screw. Some hedge fund will play it correctly of course, and collect their fees. Whatever, Merry Christmas!